Ignite Creation Date:
2025-12-26 @ 5:21 PM
Ignite Modification Date:
2026-01-22 @ 8:46 AM
Study NCT ID:
NCT01393106
Status:
COMPLETED
Last Update Posted:
2018-11-19
First Post:
2011-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma
Sponsor:
Organization: